Advertisement

Archives of Gynecology and Obstetrics

, Volume 252, Issue 2, pp 99–102 | Cite as

Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen — a case report

  • M. Klein
  • O. Krieger
  • R. Ruckser
  • A. Rosen
  • R. Waldner
  • P. Preis
  • A. Beck
Case Reports

Summary

The gender-specific prevalence of lymphangioleiomyomatosis (LAM) in premenopausal women suggests a hormonal etiology. Despite the antiestrogenic treatment (ovariectomy, tamoxifen) this disease is often refractory to therapy and almost inevitably leads to the patient's death. We describe a case where the antiproliferative effect of systemically applied interferon alpha 2b was successfully employed in addition to ovariectomy and the patient reached complete remission.

Key words

Lymphangioleiomyomatosis Interferon alpha 2b 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Banner A, Carrington C, Emory W, Kittle F, Leonard G, Ringus J, Taylor P, Addington W (1981) Efficacy of oophorectomy in lymphangioleiomyomatosis and metastasizing leiomyoma. N Engl J Med 305:204–209PubMedGoogle Scholar
  2. 2.
    Berger U, Khaghani A, Pomerance A, Yacoub M, Coombes C (1990) Pulmonary lymphangioleiomyomatosis and steroid receptors. A J C P 93:609–614.Google Scholar
  3. 3.
    Bevelaqua F (1985) Pulmonary lymphangioleiomyomatosis-long term survival in a patient with poor response to medroxyprogesterone. Chest 87:552–553PubMedGoogle Scholar
  4. 4.
    Burell L, Ross J (1937) A case of chylous effusion due to leiomyosarcoma. Br J Tuberc 31:38Google Scholar
  5. 5.
    Corrin B, Liebow A, Friedmann P (1975) Pulmonary lymphangiomyomatosis: a review. Am J Pathol 79:348–382PubMedGoogle Scholar
  6. 6.
    Dishner W, Cordasco E, Blackburn J, Demeter S, Levin H, Carey W (1984) Pulmonary lymphangioleiomyomatosis. Chest 85:796–799PubMedGoogle Scholar
  7. 7.
    Eliasson A, Phillips Y, Tenholder M (1989) Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest 96:1352–1355PubMedGoogle Scholar
  8. 8.
    McCarty K, Mossler J, McLelland R, Sieker H (1980) Pulmonary lymphangioleiomyomatosis responsive to progesterone. N Engl J Med 303:1461–1465PubMedGoogle Scholar
  9. 9.
    Orchard P, Smith C, Woods W et al. (1989) Treatment of haemangioendotheliomas with alpha interferon. Lancet II:565–567Google Scholar
  10. 10.
    Rappaport D, Weibrod G, Herman S, Chamberlain D (1989) Pulmonary lymphangioleiomyomatosis: High-Resolution CT findings in four cases. Am J Radiol 152:961–964Google Scholar
  11. 11.
    Schiaffino E, Tavani E, Dellafiore L, Schmid C (1989) Pulmonary lymphangiomyomatosis, report of a case with immunhistochemical and ultrastructural findings. Appl Pathol 7:265–272PubMedGoogle Scholar
  12. 12.
    Schönemann B, Merkle P (1990) Zur Differentialdiagnose des Spontanpneumothorax — die pulmonale lymphangioleiomyomatose. Chirurg 61:301–303PubMedGoogle Scholar
  13. 13.
    Shapiro R, Orchard P, Woods W et al. (1989) Alpha interferon therapy for “benign” vascular neoplasms. Blood 74:173Google Scholar
  14. 14.
    von Stössel E (1937) Über muskuläre Cirrhose der Lunge. Beitr Klin Tuberk 90:432–442Google Scholar
  15. 15.
    Taylor J, Ryo J, Colby T, Raffin T (1990) Lymphangioleiomyomatosis — clinical course in 32 patients. N Engl J Med 323:1254–1260PubMedGoogle Scholar
  16. 16.
    White C (1990) Treatment of hemangiomatosis with recombinant interferon alpha. Semin Hematol 27:15–22PubMedGoogle Scholar
  17. 17.
    Gresser I (1991) Antitumour effects of interferons: past, present and future. Br J Haematol 79 [Suppl] 1:1–15PubMedGoogle Scholar
  18. 18.
    Talpaz M, Kantarjian H, Kurzrock R, Guttermann J (1991) Interferon alpha in the therapy of CML. Br J Haematol 79 [Suppl] 1:38–41PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • M. Klein
    • 1
  • O. Krieger
    • 2
  • R. Ruckser
    • 3
  • A. Rosen
    • 4
  • R. Waldner
    • 5
  • P. Preis
    • 6
  • A. Beck
    • 1
  1. 1.Department of Gynecology and ObstetricsHanusch-KrankenhausViennaAustria
  2. 2.1st Medical Department, Krankenhaus der Elisabethinen, LinzLudwig Boltzmann Institute for Leukemia-research and Hematology, Hanusch-KrankenhausViennaAustria
  3. 3.2nd Medical DepartmentDonauspital SMZ OstViennaAustria
  4. 4.Department of Gynecology and ObstetricsDonauspital SMZ OstViennaAustria
  5. 5.3rd Medical DepartmentHanusch-KrankenhausVienna
  6. 6.Medical DepartmentKrankenhaus Waidhofen a.d. ThayaAustria

Personalised recommendations